shortagewatch

Home / Companies / Omega

Company family

Omega: medicine shortages

As of 2 Nov 2026, 29 Omega products have a reported shortage across 1 countries, covering 18 medicines.

Products short29rank #72 of 464
Medicines18active ingredients
Countries1/16
New in 90 days4-17 vs market pace
Typical duration4 monthsmedian so far
Manufacturing72%demand-driven 21%

Where

Canada29

Which therapeutic classes

Cardiovascular system7Systemic hormones6Blood4Nervous system3Digestive tract and metabolism3Respiratory system2Various2Dermatologicals1Musculoskeletal system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
OmegaOmega: Manufacturing problem 21 (72%)72%Omega: Increased demand 6 (21%)21%Omega: Active ingredient shortage 2 (7%)7%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

025710Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 1NovDec: 0Jan ’26: 0Feb: 1FebMar: 1Apr: 0May: 3MayJun: 2Jul: 9Aug: 3AugSep: 1Oct: 0Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0501001502002017: 820172018: 3820182019: 2620192020: 3920202021: 3120212022: 3620222023: 10420232024: 2620242025: 3920252026: 462026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Omega29

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Omega: 29 / 18Omega

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Dexamethasone426 Nov 2025Increased demand10/16
Furosemide39 Dec 2016Manufacturing problem11/16
Famotidine22 Mar 2026Increased demand4/16
Octreotide220 Jul 2026Manufacturing problem6/16
Phenylephrine21 May 2026Manufacturing problem2/16
Potassium Chloride220 Jul 2026Manufacturing problem4/16
Aminophylline128 Jun 2017Manufacturing problem2/16
Benzatropine121 Jul 2026Manufacturing problem1/16
Bupivacaine122 Jun 2026Manufacturing problem8/16
Carbohydrates129 Jun 2026Increased demand7/16
Diltiazem11 May 2026Manufacturing problem7/16
Diphenhydramine115 Nov 2026Manufacturing problem2/16
Methacholine130 Apr 2022Active ingredient shortage1/16
Naloxone130 Aug 2026Manufacturing problem2/16
Pamidronic Acid11 Jan 2013Manufacturing problem3/16
Scopolamine116 Sep 2026Manufacturing problem1/16
Thiamine (Vit B1)120 Jul 2026Increased demand3/16
Tranexamic Acid120 Jul 2026Increased demand10/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.